Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Summaria

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
American Heart Journal|February 20, 2007
The Outcome of PCI for stent-ThrombosIs MultIcentre Study (OPTIMIST): rationale and design of a multicenter registryFrancesco Burzotta, Enrico Romagnoli, Alessandro Manzoli, et al.
Journal of Clinical Medicine|June 10, 2022
Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance NetworkCarlo Lavalle, Marco Valerio Mariani, Agostino Piro, et al.
The American Journal of Cardiology|June 12, 2010
Angiographic predictors of recurrent stent thrombosis (from the Outcome of PCI for stent-ThrombosIs MultIcentre STudy [OPTIMIST])Italo Porto, Francesco Burzotta, Antonio Parma, et al.
The American Journal of Cardiology|June 24, 2015
Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary InterventionsBernardo Cortese, Alfonso Ielasi, Enrico Romagnoli, et al.
International Journal of Cardiology|January 28, 2014
Evidence from the Resorbable-polymer stent versus Unresorbable-polymer stent Deployment for coronary Intervention: (RUDI-2) registryGennaro Sardella, Carlo Briguori, Roberto Garbo, et al.
Cardiorenal Medicine|September 16, 2024
Efficacy of Modern Therapies for Heart Failure with Reduced Ejection Fraction in Specific Population Subgroups: A Systematic Review and Network Meta-AnalysisCarlo Lavalle, Marco Valerio Mariani, Paolo Severino, et al.
Journal of the American College of Cardiology|August 4, 2012
Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) studyEnrico Romagnoli, Giuseppe Biondi-Zoccai, Alessandro Sciahbasi, et al.
American Heart Journal|November 26, 2013
Radial versus femoral approach comparison in percutaneous coronary intervention with intraaortic balloon pump support: the RADIAL PUMP UP registryEnrico Romagnoli, Maria De Vita, Francesco Burzotta, et al.
The Journal of Invasive Cardiology|February 8, 2011
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registryAntonella Tommasino, Francesco Burzotta, Alessandro Sciahbasi, et al.
International Journal of Cardiology|October 24, 2021
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulationLuca Di Lullo, Carlo Lavalle, Michele Magnocavallo, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
American Heart Journal|February 20, 2007
The Outcome of PCI for stent-ThrombosIs MultIcentre Study (OPTIMIST): rationale and design of a multicenter registryFrancesco Burzotta, Enrico Romagnoli, Alessandro Manzoli, et al.
Journal of Clinical Medicine|June 10, 2022
Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance NetworkCarlo Lavalle, Marco Valerio Mariani, Agostino Piro, et al.
The American Journal of Cardiology|June 12, 2010
Angiographic predictors of recurrent stent thrombosis (from the Outcome of PCI for stent-ThrombosIs MultIcentre STudy [OPTIMIST])Italo Porto, Francesco Burzotta, Antonio Parma, et al.
The American Journal of Cardiology|June 24, 2015
Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary InterventionsBernardo Cortese, Alfonso Ielasi, Enrico Romagnoli, et al.
International Journal of Cardiology|January 28, 2014
Evidence from the Resorbable-polymer stent versus Unresorbable-polymer stent Deployment for coronary Intervention: (RUDI-2) registryGennaro Sardella, Carlo Briguori, Roberto Garbo, et al.
Cardiorenal Medicine|September 16, 2024
Efficacy of Modern Therapies for Heart Failure with Reduced Ejection Fraction in Specific Population Subgroups: A Systematic Review and Network Meta-AnalysisCarlo Lavalle, Marco Valerio Mariani, Paolo Severino, et al.
Journal of the American College of Cardiology|August 4, 2012
Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) studyEnrico Romagnoli, Giuseppe Biondi-Zoccai, Alessandro Sciahbasi, et al.
American Heart Journal|November 26, 2013
Radial versus femoral approach comparison in percutaneous coronary intervention with intraaortic balloon pump support: the RADIAL PUMP UP registryEnrico Romagnoli, Maria De Vita, Francesco Burzotta, et al.
The Journal of Invasive Cardiology|February 8, 2011
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registryAntonella Tommasino, Francesco Burzotta, Alessandro Sciahbasi, et al.
International Journal of Cardiology|October 24, 2021
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulationLuca Di Lullo, Carlo Lavalle, Michele Magnocavallo, et al.
Pageof 6